Investor Stock List
Ranked #3,756 of 8,699 institutional investors

Davern Capital Partners, LP

Ny, NY

$474M
US stock portfolio at live prices · today +$957K (+0.20%)
Live prices, last trade 10:18 AM ET
Value at quarter end (Q3 2026)
$514M
Change from Q2 2026
−$72.5M (−12.36%)
Positions
15 · 5 new, 3 sold out
Filed
Nov 12, 2026

Not counted in the ranking: none$111M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
INSM 15.3%BNTX 11.9%REGN 8.05%ARGX 7.45%IONS 6.37%
StockSharesValue, live% of portfoliovs Q2 2026
INSM Insmed Incorporated496,047$72.4M15.3%Reduced −11%
BNTX BioNTech SE682,148$56.3M11.9%Reduced −10%
REGN Regeneron Pharmaceuticals, Inc.40,661$38.2M8.05%Reduced −56%
ARGX argenx SE37,597$35.3M7.45%New
IONS Ionis Pharmaceuticals, Inc.1,087,142$30.2M6.37%Added +36%
NTRA Natera, Inc.63,200$17.7M3.72%Reduced −47%
VRDN Viridian Therapeutics, Inc.560,710$17.5M3.69%New
LLY Eli Lilly and Company12,600$17.3M3.64%New
VERA Vera Therapeutics, Inc.628,274$16.7M3.52%Added +26%
ABVX ABIVAX Société Anonyme219,183$16.0M3.37%New
LEGN Legend Biotech Corporation828,880$13.2M2.79%Reduced −30%
MLYS Mineralys Therapeutics, Inc.695,152$10.2M2.16%Reduced −19%
ARWR Arrowhead Pharmaceuticals, Inc.229,300$9.9M2.09%New
GENB Generate Biomedicines, Inc.824,679$8.7M1.83%Unchanged
AVTX Avalo Therapeutics, Inc.564,441$4.0M0.83%Added +20%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ALNY Alnylam Pharmaceuticals, Inc.113,085$17.1M
PRCT PROCEPT BioRobotics Corporation464,920$12.2M
GPCR Structure Therapeutics Inc.446,059$7.6M